Cochlear Limited
CHEOF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$9.6B
Close$
$74.23
21.5% downside
Current Fair Value
21.5% downsideOvervalued by 21.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $9.60 Billion |
|---|---|
| Enterprise Value | $9.69 Billion |
| Annual dividend | $2.43 |
| Dividend yield | 2.35% |
| Earnings per Share | $2.25 |
| Beta | 0.26 |
| Outstanding Shares | 65,398,416 |
Return
| Return on Equity | 30.81% |
|---|---|
| Return on Assets | 20.60% |
| Return on Invested Capital | 41.07% |
Valuation & Multiples
| P/E Ratio | 65.25 |
|---|---|
| PEG | -60.57 |
| Price to Sales | 1.33 |
| Price to Book Ratio | 3.64 |
| Enterprise Value to Revenue | 2.07 |
| Enterprise Value to EBIT | 11.81 |
| Enterprise Value to Net Income | 18 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.16 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
$1.17
Consensus analyst estimateRevenue Estimate
$804.03 M
Consensus analyst estimateNext Earnings Call
Expected Date
February 16, 2027
EPS Estimate
$1.82
Consensus analyst estimateRevenue Estimate
$834.98 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Cochlear Limited
5,400 employees
CEO: Diggory William Howitt
Cochlear Limited is an Australian enterprise, established in Sydney in 1981, that specializes in advanced implantable hearing technology. This global company develops and distributes a range of auditory solutions for both pediatric and a...